Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

AAvalo Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
A

Avalo Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 30, 2026Lind Kevin RobertDirector1,352Stock Option (Right to Buy)$22.3KGrant / award
Sep 30, 2026Jain RitaDirector1,322Stock Option (Right to Buy)$21.8KGrant / award
Sep 30, 2026Philip Ron MDirector1,109Stock Option (Right to Buy)$18.3KGrant / award
Sep 16, 2026Sullivan Christopher RyanChief Financial Officer12,394Common Stock$199.8KSell
Sep 16, 2026Sullivan Christopher RyanChief Financial Officer12,394Common Stock$199.8KOption exercise
Sep 10, 2026Sullivan Christopher RyanChief Financial Officer10,185Common Stock$195.9KSell
Sep 10, 2026Sullivan Christopher RyanChief Financial Officer10,185Common Stock$195.9KOption exercise
Aug 28, 2026Doyle MittieChief Medical Officer679Common Stock$13.3KSell
Aug 28, 2026Doyle MittieChief Medical Officer679Common Stock$13.3KOption exercise
Aug 18, 2026Sullivan Christopher RyanChief Financial Officer31,031Common Stock$607.9KSell
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$16.51Close · Sep 22, 2026